Abstract
Gestational diabetes mellitus (GDM) is defined as carbohydrate intolerance with onset or first recognition during pregnancy. When medical nutrition therapy is not successful in maintaining target glucose values during pregnancy complicated by GDM, medication is required. Insulin has been the traditional treatment under such circumstances. The use of oral antidiabetic medications in the management of gestational diabetes has increased over the past several years. Recent studies have shown the equivalence to insulin of both glyburide and metformin in terms of pregnancy outcomes in GDM. However, both agents have been shown to cross the placenta to the fetus, and thus they should be used with caution and patients counseled appropriately.
Similar content being viewed by others
References and Recommended Reading
Hunt KJ, Schuller KL: The increasing prevalence of diabetes in pregnancy. Obstet Gynecol Clin North Am 2007, 34:173–199.
Langer O: Maternal glycemic criteria for insulin therapy in gestational diabetes mellitus. Diabetes Care 1998, 21(Suppl 2):B91–B98.
Langer O, Rodriguez DA, Xenakis EM, et al.: Intensified vs. conventional management of gestational diabetes. Am J Obstet Gynecol 1994, 170:1036–1047.
Crowther CA, Hiller JE, Moss JR, et al.: Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005, 352:2477–2486.
American Diabetes Association: Gestational diabetes mellitus. Diabetes Care 2004, 27(Suppl 1):S88–S90.
American College of Obstetricians and Gynecologists: Gestational Diabetes: ACOG Practice Bulletin No. 30. Obstet Gynecol 2001, 98:525–538.
DeFronzo RA, Simonson DC: Oral sulfonylurea agents suppress hepatic glucose production in non-insulin-dependent diabetic individuals. Diabetes Care 1984, 7:724–727.
Rossetti L, Giaaccari A, DeFronzo RA: Glucose toxicity. Diabetes Care 1990, 13:610–630.
Simonson DC, Farrannini E, Bevilacqua S, et al.: Mechanism of improvement in glucose metabolism after chronic glyburide therapy. Diabetes Care 1984, 33:838–845.
Elliot B, Langer O, Schenker S, Johnson RF: Insignificant transfer of glyburide occurs across the human placenta Am J Obstet Gynecol 1991, 165:807–812.
Elliot B, Schenker S, Langer O, et al.: Comparative placental transport of oral hypoglycemic agents: a model of human placental drug transfer. Am J Obstet Gynecol 1994, 171:653–660.
Elliot B, Langer O, Schussling F: A model of human placental drug transfer. Am J Obstet Gynecol 1997, 176:527–530.
Langer O, Conway DL, Berkus MD, et al.: A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med 2000, 343:1134–1138.
Hebert MF, Ma X, Naraharisetti SB, et al., for the Obstetric-Fetal Pharmacology Research Unit Network: Are we optimizing gestational diabetes treatment with glyburide? The pharmacologic basis for better clinical practice. Clin Pharmacol Ther 2009, 85:607–614.
Yogev Y, Ben-Haroush A, Chen R, et al.: Undiagnosed asymptomatic hypoglycemia: diet, insulin and glyburide for gestational diabetic pregnancy. Obstet Gynecol 2004, 104:88–93.
Rochon M, Rand L, Roth L, Sreedhar G: Glyburide for the management of gestational diabetes: risk factors predictive of failure and associated pregnancy outcomes. Am J Obstet Gynecol 2006, 195:1090–1094.
Jacobson GF, Ramos GA, Ching JY, et al.: Comparison of glyburide and insulin for the management of gestational diabetes in a large managed care organization. Am J Obstet Gynecol 2005, 193:118–124.
Vanky E, Zahlsen K, Spigset O, Carlsen SM: Placental passage of metformin in women with polycystic ovary syndrome. Fertil Steril 2005, 83:1575–1578.
Boney CM, Verma A, Tucker R, Vohr BR: Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics 2005, 115:e290–e296.
Rowan JA, Hague WM, Wanzhen G, et al.: Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med 2008, 358:2003–2015.
Chan LY, Yeung JH, Lau TK: Placental transfer of rosiglitazone in the first trimester of human pregnancy. Fertil Steril 2005, 83:955–958.
Zarate A, Ochoa R, Hernandez M, et al.: Eficacia de la acarbose para controlar el deterioro de la tolerancia a la glucose durante la gestacio [Spanish]. Ginecol Obstet Mex 2000, 68:42–45.
deVeciana M, Trail PA, Lau TK, Dulaney K: A comparison of oral acarbose and insulin in women with gestational diabetes mellitus. Obstet Gynecol 2002, 99(Suppl.):5S.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Paglia, M.J., Coustan, D.R. The use of oral antidiabetic medications in gestational diabetes mellitus. Curr Diab Rep 9, 287–290 (2009). https://doi.org/10.1007/s11892-009-0044-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11892-009-0044-3